125 related articles for article (PubMed ID: 32010480)
1. Predictive Value of Pin1 in Cervical Low-Grade Squamous Intraepithelial Lesions and Inhibition of Pin1 Exerts Potent Anticancer Activity against Human Cervical Cancer.
Guo YT; Lu Y; Jia YY; Qu HN; Qi D; Wang XQ; Song PY; Jin XS; Xu WH; Dong Y; Liang YY; Quan CS
Aging Dis; 2020 Feb; 11(1):44-59. PubMed ID: 32010480
[TBL] [Abstract][Full Text] [Related]
2. A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action.
Campaner E; Rustighi A; Zannini A; Cristiani A; Piazza S; Ciani Y; Kalid O; Golan G; Baloglu E; Shacham S; Valsasina B; Cucchi U; Pippione AC; Lolli ML; Giabbai B; Storici P; Carloni P; Rossetti G; Benvenuti F; Bello E; D'Incalci M; Cappuzzello E; Rosato A; Del Sal G
Nat Commun; 2017 Jun; 8():15772. PubMed ID: 28598431
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the PIN1-NRF2/GPX4 axis imparts sensitivity to cisplatin in cervical cancer cells.
Zhang Z; Hu Q; Ye S; Xiang L
Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 54(9):1325-1335. PubMed ID: 35983979
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of prolyl isomerase Pin1 promotes cervical tumorigenesis and metastasis.
Ma JQ; Yang Y; Juan J; Guo CF; Tuerxun M; Ting W; Hasim A
Int J Clin Exp Pathol; 2018; 11(2):664-674. PubMed ID: 31938152
[TBL] [Abstract][Full Text] [Related]
5. Use of peripheral blood transcriptomic biomarkers to distinguish high-grade cervical squamous intraepithelial lesions from low-grade lesions.
Zou C; Lyu Y; Jiang J; Cao Y; Wang M; Sang C; Zhang R; Li H; Liew CC; Cheng C; Zhao S
Oncol Lett; 2020 Sep; 20(3):2280-2290. PubMed ID: 32765790
[TBL] [Abstract][Full Text] [Related]
6. Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways.
Lian X; Lin YM; Kozono S; Herbert MK; Li X; Yuan X; Guo J; Guo Y; Tang M; Lin J; Huang Y; Wang B; Qiu C; Tsai CY; Xie J; Gao ZJ; Wu Y; Liu H; Zhou XZ; Lu KP; Chen Y
J Hematol Oncol; 2018 May; 11(1):73. PubMed ID: 29848341
[TBL] [Abstract][Full Text] [Related]
7. Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways.
Liao XH; Zhang AL; Zheng M; Li MQ; Chen CP; Xu H; Chu QS; Yang D; Lu W; Tsai TF; Liu H; Zhou XZ; Lu KP
Sci Rep; 2017 Mar; 7():43639. PubMed ID: 28262728
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of Cytokeratin 7 Immunohistochemistry in Cervical Low-grade Squamous Intraepithelial Lesion as a Marker for Risk of Progression to a High-grade Lesion.
Paquette C; Mills AM; Stoler MH
Am J Surg Pathol; 2016 Feb; 40(2):236-43. PubMed ID: 26551618
[TBL] [Abstract][Full Text] [Related]
9. Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways.
Zhang Z; Yu W; Zheng M; Liao X; Wang J; Yang D; Lu W; Wang L; Zhang S; Liu H; Zhou XZ; Lu KP
Mol Carcinog; 2019 Aug; 58(8):1450-1464. PubMed ID: 31026381
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
[TBL] [Abstract][Full Text] [Related]
11. Autophagy regulated by prolyl isomerase Pin1 and phospho-Ser-GSK3αβ involved in protection of oral squamous cell carcinoma against cadmium toxicity.
So KY; Ahn SG; Oh SH
Biochem Biophys Res Commun; 2015 Oct; 466(3):541-6. PubMed ID: 26381174
[TBL] [Abstract][Full Text] [Related]
12. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.
Zheng M; Xu H; Liao XH; Chen CP; Zhang AL; Lu W; Wang L; Yang D; Wang J; Liu H; Zhou XZ; Lu KP
Oncotarget; 2017 May; 8(18):29771-29784. PubMed ID: 28404959
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-370 in esophageal squamous-cell carcinoma is associated with cancer progression and promotes cancer cell proliferation via upregulating PIN1.
Chen M; Xia Y; Tan Y; Jiang G; Jin H; Chen Y
Gene; 2018 Jun; 661():68-77. PubMed ID: 29605603
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of peptidyl-prolyl isomerase (PIN1) and BRAF signaling to target melanoma.
Braun C; Schneider N; Pei D; Bosserhoff A; Kuphal S
Am J Transl Res; 2019; 11(7):4425-4437. PubMed ID: 31396346
[TBL] [Abstract][Full Text] [Related]
16. HPV genotype distribution and anomalous association of HPV33 to cervical neoplastic lesions in San Luis Potosí, Mexico.
DelaRosa-Martínez R; Sánchez-Garza M; López-Revilla R
Infect Agent Cancer; 2016; 11():16. PubMed ID: 27030798
[TBL] [Abstract][Full Text] [Related]
17. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
Wang T; Liu Z; Shi F; Wang J
Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
[TBL] [Abstract][Full Text] [Related]
18. Stathmin is a highly sensitive and specific biomarker for vulvar high-grade squamous intraepithelial lesions.
Nooij LS; Dreef EJ; Smit VT; van Poelgeest MI; Bosse T
J Clin Pathol; 2016 Dec; 69(12):1070-1075. PubMed ID: 27226646
[TBL] [Abstract][Full Text] [Related]
19. Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intraepithelial lesion.
Sakane J; Taniyama K; Miyamoto K; Saito A; Kuraoka K; Nishimura T; Sentani K; Oue N; Yasui W
Diagn Cytopathol; 2015 Jun; 43(6):462-70. PubMed ID: 25614457
[TBL] [Abstract][Full Text] [Related]
20. Pin1 contributes to cervical tumorigenesis by regulating cyclin D1 expression.
Li H; Wang S; Zhu T; Zhou J; Xu Q; Lu Y; Ma D
Oncol Rep; 2006 Sep; 16(3):491-6. PubMed ID: 16865248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
